A research team backed by a federal grant has created a genetically engineered mousepox virus designed to evade vaccines, highlighting the deadly potential of biotechnology and bioterrorism.
The team at St. Louis University, led by Mark Buller, created the superbug to figure out how to defeat it, a key goal of the government's anti-terrorism plan.
Researchers designed a two-drug cocktail that promises to defeat their exceptionally deadly virus. They hope to publish their work soon in a peer review journal.
"The whole focus was to contribute to the biodefense agenda of the country," Buller said.
MORE